Skip to content

"Safety in Dementia": An Online Caregiver Intervention

"Safety in Dementia": An Online Caregiver Intervention

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05173922
Enrollment
500
Registered
2021-12-30
Start date
2022-05-22
Completion date
2024-10-11
Last updated
2026-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Caregivers, Decision Making, Safety, Social Media, Suicide

Brief summary

In an online randomized trial of Safety in Dementia with national recruitment and longitudinal follow-up, we will recruit informal caregivers of community-dwelling adults with dementia who have firearm access.

Detailed description

Aim 1: To test the efficacy of Safety in Dementia (SiD) on firearm safety decision quality and behaviors, among a national sample of informal caregivers of community-dwelling people with dementia and firearm access (n=500). Aim 2: To compare varied methods in reaching informal caregivers. Aim 3: To explore stakeholder longitudinal experiences with SiD and firearm-related decisions.

Interventions

BEHAVIORALSafety in Dementia

Safety in Dementia is an online tool that, in a stepwise fashion, guides a caregiver individual through decisions related to firearm access for a person with dementia. It includes information and a comparison of the options and their risks and benefits. It guides the caregiver through clarification of personal feelings and values and identifying their decision/plan. The control group will view national Institute on Aging Home Safety Checklist.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Live in United States * Speak English or Spanish * Informal caregiver for community swelling person with dementia and firearm access * Access to the internet

Exclusion criteria

* In legal custody or institutionalized

Design outcomes

Primary

MeasureTime frameDescription
Preparation for Decision MakingDuring baseline assessment (specifically, after receiving randomization allocation), 2 weeks, 2 months, 6 monthsThe Preparation for Decision Making Scale assesses perception of how useful a decision aid is in preparing for subsequent decision-making. Scores range from 1-5, calculated from the sum of 10 constructs (each ranging from 1, 'not at all' to 5, 'a great deal'). The total score is calculated by first summing the 10 items and dividing by 10 to find an average item response score. Then, we subtract 1 from the summed score and multiply this by 25 to convert the final score to a 0-100 scale with higher scores indicating higher perceived levels of preparation for decision making (higher = better). The scale has high test reliability (0.944) and discriminates significantly between different decision support interventions.

Secondary

MeasureTime frameDescription
Decision Self-Efficacybaseline/pre-intervention, 2 weeks, 2 months, 6 monthsThe Decision Self-Efficacy Scale measures confidence in ability to make decisions; transformed scores range from 0 (extremely low, worst outcome) to 100 (extremely high self-efficacy, best outcome).
Number of People With Dementia Who Retained Firearm Access2 weeks, 2 months, 6 monthsFirearm access for the person with ADRD will be assessed with scales we have used in prior work, allowing nuanced (but efficient) description of firearm access (on a scale ranging from access to multiple loaded firearms to no access to any firearms). For reporting and analysis, we will use binary categorization (caregiver reports that person with dementia still has access to 1+ firearm \[1\] versus person with dementia no longer has access to any firearms \[0\])
Number of Participants Who Took Action to Reduce Firearm Access for Person With DementiaBaseline, 2 weeks, 2 months, 6 monthsAt each time point, participants self-reported if they have taken any steps to reduce firearm access for the person with dementia. Nine response options associated with this question are used to calculate this binary outcome (1+ actions taken versus no action taken). If they selected 'yes' to any of the following options, their outcome was '1+ action taken' (1); if they selected 'no' to all, their outcome was 'no action taken' (0). The nine response options were: (1) used a/more locking devices, (2) used a/more locking safes or gun lockboxes, (3) gave a/more guns to a trusted family member for temporary safekeeping, (4) gave a/more guns to a trusted friend for temporary safekeeping, (5) stored a/more guns at a store or range that has firearm storage, (6) stored a/more guns at a law enforcement agency temporarily, (7) gave a/multiple guns to law enforcement permanently, (8) sold, gave or transferred a/multiple guns to family or friends, and (9) sold a/multiple guns to the public.
Firearm Injurybaseline/pre-intervention, 2 weeks, 2 months, 6 monthsWe will assess injuries involving the person with ADRD and a firearm. Participants will be asked about any such incidents in the prior year (baseline) or since enrollment (follow-up) and a brief description.
Caregiver Burden2 weeksThe short-form Zarit Burden Interview has scores ranging from 0-48, calculated from 12 items (measured on a 5-point scale from 0, never to 4, nearly always); scores range from 0 to 12 with higher scores reflecting higher burden.
Positive Aspects of Caregiving2 weeksThe Positive Aspects of Caregiving Scale has scores ranging from 0-36, calculated from the sum of 9 items (measured on a 5-point scale ranging from 0, disagree a lot, to 4, agree a lot, on statements such as feel more useful), with higher scores indicating more positive caregiving experiences.

Countries

United States

Participant flow

Pre-assignment details

Of N = 522 eligible participants who consented and were sent the survey invitation, N = 22 did not begin the survey or stopped completing the survey before randomization and viewing of the control or Safe at Home information. Therefore, the sample is comprise of N = 500 individuals who were enrolled and randomized.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
30 Participants
Age, Categorical
Between 18 and 65 years
202 Participants
Age, Continuous46.4 years
STANDARD_DEVIATION 14.6
Ethnicity (NIH/OMB)
Hispanic or Latino
22 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
428 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
16 Participants
Preparation for decision-making69.8 units on a scale
STANDARD_DEVIATION 22
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants
Race (NIH/OMB)
Asian
5 Participants
Race (NIH/OMB)
Black or African American
144 Participants
Race (NIH/OMB)
More than one race
7 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
11 Participants
Race (NIH/OMB)
White
156 Participants
Region of Enrollment
United States
251 participants
Sex: Female, Male
Female
162 Participants
Sex: Female, Male
Male
82 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2490 / 251
other
Total, other adverse events
36 / 24931 / 251
serious
Total, serious adverse events
9 / 24911 / 251

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026